3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Breast Neoplasms
12
Neuroendocrine Tumors
5
Neoplasm Metastasis
5
Carcinoma, Renal Cell
4
Triple Negative Breast Neoplasms
3
Adenoma, Islet Cell
3
Recurrence
2
Meningioma
2
Glioblastoma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Hepatocellular
2
Carcinoid Tumor
2
von Hippel-Lindau Disease
1
Unilateral Breast Neoplasms
1
Tuberous Sclerosis
1
Thymus Neoplasms
1
Sarcoma
1
Neoplasms
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Lymphangioleiomyomatosis
1
Locally Advanced Thyroid Gland Carcinoma
1
Kidney Neoplasms
1
HR+/HER2- Advanced Breast Cancer
1
Glioma
1
Gastroenteropancreatic Neuroendocrine Tumors
1
Gastro-enteropancreatic neuroendocrine tumor
1
Gallbladder Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Radiosurgery
2
neratinib
1
lutetium Lu 177 dotatate
1
capivasertib
1
avasopasem manganese
1
Valproic Acid
1
Taxes
1
Sevoflurane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Propofol
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Gemcitabine
1
Everolimus
1
Etoposide
1
Cystectomy
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Cisplatin
1
Carboplatin
1
Blood Specimen Collection
1
Biopsy
1
Anesthesia, Inhalation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Disease Progression
×
Everolimus
×
Clear all
NCT06472388
2024-06-25
EVENET
AC Camargo Cancer Center
Phase 2
Recruiting
100 enrolled